Inhibitory Effect of Loranthus parasiticus on IgE-Mediated Allergic Responses in RBL-2H3 Cells

被引:6
作者
Yoo, Jae-Myung [1 ]
Yang, Ju-Hye [1 ]
Kim, Young Soo [1 ]
Cho, Won-Kyung [1 ]
Ma, Jin Yeul [1 ]
机构
[1] KIOM, Korean Med KM Applicat Ctr, Daegu 41062, South Korea
关键词
MAST-CELL; ACTIVATION; EXTRACT;
D O I
10.1155/2016/8742562
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mistletoe Loranthus parasiticus has been used as a compound for traditional medicine in Northeast Asia for a long time and is known to possess neuroprotective action. Nonetheless, the effect of Loranthus parasiticus on allergic responses remains unknown. In the present study, we evaluated whether the water extract of Loranthus parasiticus (LPE) could inhibit IgE-mediated allergic responses in RBL-2H3 cells. LPE inhibited the release of beta-hexosaminidase (IC50, 184.5 mu g/mL) and the formation of tumor necrosis factor-alpha (IC50, 84.27 mu g/mL), interleukin-4 (IC50, 93.43 mu g/mL), prostaglandin E-2 (IC50, 84.10 mu g/mL), prostaglandin D 2, and leukotriene C-4 (IC50, 43.27 mu g/mL) in a concentration-dependent manner. Moreover, LPE inhibited phosphorylation of Syk, PLC gamma 1/2, PKC delta, ERK, JNK, p38, and Akt. In the late phase, LPE decreased 5-lipoxygenase phosphorylation and COX-2 expression but not cPLA(2) phosphorylation. Additionally, LPE included total phenolic compounds (10.72 mg/g dry weight) and total flavonoids (56.20mg/g dry weight). These results suggest that the phenolic compounds or flavonoids contained in LPE may be associated with antiallergic activity. The phenolic compounds and flavonoids in LPE are antiallergic phytochemicals capable of inhibiting the activation of the Fc epsilon RI signaling cascade in mast cells. Such effects may provide further information for the development of a phytomedicine for allergic diseases.
引用
收藏
页数:8
相关论文
共 21 条
[1]  
[Anonymous], EVID BASED COMPLEMEN
[2]   Effectiveness of the Novel Herbal Medicine, KIOM-MA, and Its Bioconversion Product, KIOM-MA128, on the Treatment of Atopic Dermatitis [J].
Chung, Tae Ho ;
Kang, Tae Jin ;
Cho, Won-Kyung ;
Im, Ga Young ;
Lee, Geum Seon ;
Yang, Min Cheol ;
Cho, Chang-Won ;
Ma, Jin Yeul .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
[3]   The human mast cell [J].
Church, MK ;
LeviSchaffer, F .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (02) :155-160
[4]   LEUKOTRIENE-B, A POTENT CHEMOKINETIC AND AGGREGATING SUBSTANCE RELEASED FROM POLYMORPHONUCLEAR LEUKOCYTES [J].
FORDHUTCHINSON, AW ;
BRAY, MA ;
DOIG, MV ;
SHIPLEY, ME ;
SMITH, MJH .
NATURE, 1980, 286 (5770) :264-265
[5]   Regulation of Mast Cell Responses in Health and Disease [J].
Gilfillan, Alasdair M. ;
Beaven, Michael A. .
CRITICAL REVIEWS IN IMMUNOLOGY, 2011, 31 (06) :475-529
[6]   Integrated signalling pathways for mast-cell activation [J].
Gilfillan, AM ;
Tkaczyk, C .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) :218-230
[7]  
Gorter R W, 1998, Am J Ther, V5, P181, DOI 10.1097/00045391-199805000-00009
[8]  
Hwang K, 2011, PLANTA MED, V77, P1322
[9]  
Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
[10]   Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation [J].
Kawakami, Y ;
Kitaura, J ;
Satterthwaite, AB ;
Kato, RM ;
Asai, K ;
Hartman, SE ;
Maeda-Yamamoto, M ;
Lowell, CA ;
Rawlings, DJ ;
Witte, ON ;
Kawakami, T .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1210-1219